Comparison of Influenza Disease Burden in Older Populations of Hong Kong and Brisbane: the Impact of Influenza and Pneumococcal Vaccination

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2019 Feb 16

PMID 30764779

Citations 5

Authors

Lin Yang

King Pan Chan

Chit Ming Wong

Susan Shui Seng Chiu

Ricardo J Soares Magalhaes

Thuan Quoc Thach

Joseph Syrial Malik Peiris

Archie C A Clements

Wenbiao Hu

Affiliations

Soon will be listed here.

Abstract

Background: Influenza and pneumococcal vaccine uptake in the older population aged 65 years or over of Hong Kong dramatically increased since the 2003 SARS outbreak. This study is aimed to evaluate the impact of increased coverage of influenza and pneumococcal vaccines by comparing the change of disease burden in the older population of Hong Kong, with the burden in the older population of Brisbane with relatively high vaccine coverage in the past fifteen years.

Methods: Time series segmented regression models were applied to weekly numbers of cause-specific mortality or hospitalization of Hong Kong and Brisbane. Annual excess rates of mortality or hospitalization associated with influenza in the older population were estimated for the pre-SARS (reference period), post-SARS and post-pandemic period, respectively. The rate ratios (RRs) between these periods were also calculated to assess the relative change of disease burden.

Results: Compared to the pre-SARS period, excess rates of mortality associated with influenza during the post-SARS period in Hong Kong decreased for cardiorespiratory diseases (RR = 0.90, 95% CI 0.80, 1.01), stroke (RR = 0.74, 95% CI 0.50, 1.09), and ischemic heart diseases (RR = 0.45, 95% CI 0.34, 0.58). The corresponding RRs in Brisbane were 0.79 (95% CI 0.54, 1.15), 0.33 (0.13, 0.80), and 1.09 (0.62, 1.90), respectively. Only the mortality of ischemic heart diseases showed a greater reduction in Hong Kong than in Brisbane. During the post-pandemic period, excess rates of all-cause mortality increased in Hong Kong, but to a lesser extent than in Brisbane (RR = 1.41 vs 2.39).

Conclusion: A relative decrease (or less of an increase) of influenza disease burden was observed in the older population of Hong Kong after increased coverage of influenza and pneumococcal vaccines in this population, as compared to those of Brisbane where vaccination rates remained stable. The lack of significant findings in some disease categories highlights the challenges of evaluating the benefits of vaccination at the population level.

Citing Articles

Population-level benefits of increasing influenza vaccination uptake among Italian older adults: results from a granular panel model.

Domnich A, Orsi A, Panatto D, Ogliastro M, Barca A, Bert F Front Public Health. 2023; 11:1224175.

PMID: 37601177 PMC: 10435743. DOI: 10.3389/fpubh.2023.1224175.

A Systematic Review and Meta-Analysis of the Relationship between Receiving the Flu Vaccine with Acute Cerebrovascular Accident and Its Hospitalization in the Elderly.

Tavabe N, Kheiri S, Dehghani M, Mohammadian-Hafshejani A Biomed Res Int. 2023; 2023:2606854.

PMID: 36814798 PMC: 9940958. DOI: 10.1155/2023/2606854.

Global and national influenza-associated hospitalisation rates: Estimates for 40 countries and administrative regions.

Paget J, Staadegaard L, Wang X, Li Y, van Pomeren T, van Summeren J J Glob Health. 2023; 13:04003.

PMID: 36701368 PMC: 9879557. DOI: 10.7189/jogh.13.04003.

Essential Oils and Their Compounds as Potential Anti-Influenza Agents.

Oriola A, Oyedeji A Molecules. 2022; 27(22).

PMID: 36431899 PMC: 9693178. DOI: 10.3390/molecules27227797.

A Hospital-Based Nonconcurrent Cohort Study on Factors Associated with in-Hospital Mortality in Patients with Laboratory Confirmed Influenza.

Alexander V, Paul G, Zachariah A, Mathuram A J Glob Infect Dis. 2021; 12(4):208-213.

PMID: 33888959 PMC: 8045533. DOI: 10.4103/jgid.jgid_45_20.

References

van Essen G, Palache A, Forleo E, Fedson D . Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine. 2003; 21(16):1780-5. DOI: 10.1016/s0264-410x(03)00072-0. View

Simonsen L, Reichert T, Viboud C, Blackwelder W, Taylor R, Miller M . Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med. 2005; 165(3):265-72. DOI: 10.1001/archinte.165.3.265. View

Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A, Di Pietrantonj C . Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet. 2005; 365(9461):773-80. DOI: 10.1016/S0140-6736(05)17984-7. View

. Influenza vaccines. Wkly Epidemiol Rec. 2005; 80(33):279-87. View

Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V . Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet. 2005; 366(9492):1165-74. DOI: 10.1016/S0140-6736(05)67339-4. View

Goodwin K, Viboud C, Simonsen L . Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2005; 24(8):1159-69. DOI: 10.1016/j.vaccine.2005.08.105. View

Wong C, Yang L, Chan K, Leung G, Chan K, Guan Y . Influenza-associated hospitalization in a subtropical city. PLoS Med. 2006; 3(4):e121. PMC: 1391978. DOI: 10.1371/journal.pmed.0030121. View

Hui S, Chu L, Peiris J, Chan K, Chu D, Tsui W . Immune response to influenza vaccination in community-dwelling Chinese elderly persons. Vaccine. 2006; 24(25):5371-80. DOI: 10.1016/j.vaccine.2006.04.032. View

Jefferson T, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V . Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2007; (2):CD001269. DOI: 10.1002/14651858.CD001269.pub3. View

10.

Simonsen L, Taylor R, Viboud C, Miller M, Jackson L . Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007; 7(10):658-66. DOI: 10.1016/S1473-3099(07)70236-0. View

11.

Nichol K, Nordin J, Nelson D, Mullooly J, Hak E . Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007; 357(14):1373-81. DOI: 10.1056/NEJMoa070844. View

12.

Cowling B, Fung R, Cheng C, Fang V, Chan K, Seto W . Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households. PLoS One. 2008; 3(5):e2101. PMC: 2364646. DOI: 10.1371/journal.pone.0002101. View

13.

Kwong J, Stukel T, Lim J, McGeer A, Upshur R, Johansen H . The effect of universal influenza immunization on mortality and health care use. PLoS Med. 2008; 5(10):e211. PMC: 2573914. DOI: 10.1371/journal.pmed.0050211. View

14.

Jefferson T, Di Pietrantonj C, Al-Ansary L, Ferroni E, Thorning S, Thomas R . Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2010; (2):CD004876. DOI: 10.1002/14651858.CD004876.pub3. View

15.

Ou C, Wong C, Ho S, Schooling M, Yang L, Hedley A . Dietary habits and the short-term effects of air pollution on mortality in the Chinese population in Hong Kong. J Epidemiol Community Health. 2010; 66(3):254-8. DOI: 10.1136/jech.2009.103275. View

16.

Yang L, Chan K, Cowling B, Chiu S, Chan K, Peiris J . Excess mortality associated with the 2009 pandemic of influenza A(H1N1) in Hong Kong. Epidemiol Infect. 2011; 140(9):1542-50. DOI: 10.1017/S0950268811002238. View

17.

Wang X, Yang L, Chan K, Chiu S, Chan K, Peiris J . Model selection in time series studies of influenza-associated mortality. PLoS One. 2012; 7(6):e39423. PMC: 3380027. DOI: 10.1371/journal.pone.0039423. View

18.

Wu P, Goldstein E, Ho L, Yang L, Nishiura H, Wu J . Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009. J Infect Dis. 2012; 206(12):1862-71. PMC: 3502382. DOI: 10.1093/infdis/jis628. View

19.

Beyer W, McElhaney J, Smith D, Monto A, Nguyen-Van-Tam J, Osterhaus A . Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine. 2013; 31(50):6030-3. DOI: 10.1016/j.vaccine.2013.09.063. View

20.

Wang X, Yang L, Chan K, Chan K, Cao P, Lau E . Age and Sex Differences in Rates of Influenza-Associated Hospitalizations in Hong Kong. Am J Epidemiol. 2015; 182(4):335-44. DOI: 10.1093/aje/kwv068. View